Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial - Cortes, J E; Gambacorti-Passerini, C; Deininger, M W (J Clin Oncol, 2018)
et al.